Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

Published 2015 View Full Article

Authors

Keywords

Familial prostate cancer, Intraductal carcinoma, BRCA2, germline mutations, Patient-derived xenografts, Pathology

Journal

EUROPEAN UROLOGY

Volume 67, Issue 3, Pages 496-503

Publisher

Elsevier BV

Online

2014-08-23

DOI

10.1016/j.eururo.2014.08.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now